核磁共振輔助經直腸超音波切片於攝護腺癌診斷的臨床應用價值
邱鴻傑、謝博帆、黃志平、吳錫金、張兆祥
中國醫藥大學附設醫院 泌尿部
The clinical value of cognitive-registration magnetic resonance imaging trans-rectal ultrasound biopsy in clinical prostate cancer detection
Hung-Chieh Chiu, Po-Fan Hsieh, Chi-Ping Huang, His-Chin Wu, Chao-Hsiang Chang  
Department of Urology, China Medical University Hospital, Taichung, Taiwan
 
Purpose:
    The utilization of magnetic resonance imaging for target biopsy is growing gradually and it maximizes the clinical prostate cancer detection based on previous reports. The cognitive-registration MRI biopsy is the simplest, cheapest way without compromising the detection rate. The aim of our study is to compared the detection rate for prostate cancer in re-biopsy patient group between MRI cognitive-registration biopsy and conventional trans-rectal ultrasound-guided biopsy.
 
Materials and Methods:
    Patients underwent trans-rectal ultrasound biopsy from Jan. 2012 to Dec. 2014 were retrospectively reviewed. In the re-biopsy group. they were divided into Group I: MRI cognitive-registration biopsy and Group II: conventional trans-rectal ultrasound-guided biopsy. The parameter of patient’s character and prostate cancer detection rate were compared.
 
Results:
    1351 patients underwent trans-rectal ultrasound biopsy and 445 (32.42%) prostate cancer were diagnosed, while 906 patients (67.58%) remained negative for prostate cancer. 179 patients (13.25%) underwent re-biopsy owing to persist elevated PSA level. They were divided into two groups, 61 patients were enrolled in Group I: MRI cognitive-registration biopsy while 118 patients were enrolled in Group II: conventional trans-rectal ultrasound-guided biopsy. There was no significant difference between two groups in age , PSA level and biopsy burden. But the detection rate for prostate cancer is higher in MRI cognitive-registration biopsy than conventional trans-rectal ultrasound-guided biopsy. (44.26% VS 21.18% , p=0.001)
      
Conclusions:
    MRI cognitive-registration biopsy increased the detection rate for prostate cancer than conventional trans-rectal ultrasound-guided biopsy. It maybe reduced the biopsy burden and associated cost, although it didn’t show statistically significant difference in our study. 
 
 
    位置
    資料夾名稱
    摘要
    發表人
    TUA秘書處
    單位
    台灣泌尿科醫學會
    標籤
    口頭報告
    建立
    2016-05-30 21:32:00
    最近修訂
    2016-05-30 21:33:31
    更多